Autopsy report · NCT02827552
Description of Individual Radiosensitivity With Molecular Biomarkers in a Pediatric Oncology Population
Cause of deathSlow enrollment
“The liquidation of our industrial partner NEOLYS Diagnostics, directly involved in the methodology of the study and a sub-optimal rate of inclusions which did not allow us to include all patient within the allotted time.”
Life of this trial
- Registered 8 months before it started.
- Ran for about 2 years 11 months before it stopped.
- 40 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Institut de Cancérologie de Lorraine
- Sponsor type
- University, hospital or other
- Conditions
- Cancer-related Problem/Condition
- Interventions
- skin biopsy
- Participants
- 40
- Sites
- 11
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.